Skip to main content

Advertisement

ADVERTISEMENT

Volume 13 - Issue 2 - February 2016

01/26/2016
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a...
01/26/2016
Vascular Disease Management
01/26/2016
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a...
01/26/2016
Vascular Disease Management
01/26/2016
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a...
01/26/2016
Vascular Disease Management
01/26/2016
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a...
01/26/2016
Vascular Disease Management
01/26/2016
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management...
01/26/2016
Vascular Disease Management
01/26/2016
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management...
01/26/2016
Vascular Disease Management
01/26/2016

Mark J. Russo, MD1; Ross Milner, MD2; Atman P. Shah, MD2

 

1Barnabas Heart Health Centers, Newark, New Jersey; 2University of Chicago Medicine, Chicago, Illinois

Mark J. Russo, MD1; Ross Milner, MD2;...
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of...
01/26/2016
Vascular Disease Management
01/26/2016
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine...
01/26/2016
Vascular Disease Management
01/26/2016

Roy Miler, MD1; Christopher R. Marcellino, MD2; Rocio T. Moran, MD3; Matthew J. Eagleton, MD1; Chase R. Brown, MD1; James Bena, MD1; Tara M. Mastracci, MD4

 

1Cleveland Clinic, Cleveland, Ohio; 2Case Western Reserve University, Cleveland, Ohio; 3MetroHealth Medical Center, Cleveland, Ohio; 4Royal Free London NHS Foundation Trust, London, United Kingdom.

Roy Miler, MD1; Christopher R. Marcel...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine...
01/26/2016
Vascular Disease Management

Feature

Case Report
01/26/2016
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of...
01/26/2016
Vascular Disease Management

Advertisement

Advertisement

Advertisement